| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	5-FU
				
			5-fluorocytosine
				
			BCNU
				
			CAS 76095-16-4
				
			CAS 76420-72-9
				
			Glat copolymer
				
			K779
				
			L-Dmp
				
			LiOH
				
			Lisinopril
				
			MK-462
				
			Stalevo 50
				
			VACV
				
				
					Ataxia: very rare, postmarketing Zyprexa Relprevv
				
			acetazolamide
				
			acyclovir
				
				
					Ataxia: very rare, postmarketing allopurinol
				
			alprazolam
				
			amantadine
				
			amiodarone
				
			amitriptyline
				
			amlodipine
				
			amlodipine besylate
				
			amobarbital
				
			amoxapine
				
			amphetamine
				
			anthracycline
				
			aripiprazole
				
			atenolol
				
			atropine
				
			baclofen
				
			betaxolol
				
			bexarotene
				
			bortezomib
				
			bromazepam
				
				
					Ataxia: postmarketing, 13% bromocriptine
				
			bupropion
				
				
					Ataxia: postmarketing, rare, frequent buspirone
				
			butabarbital
				
			butorphanol
				
			cabozantinib
				
			capecitabine
				
			captopril
				
			carbamazepine
				
				
					Ataxia: postmarketing, very common, 5% - 15% carbidopa
				
			carisoprodol
				
			ceftriaxone
				
			celecoxib
				
			cetirizine
				
			chlorambucil
				
			chlordiazepoxide
				
			cidofovir
				
			cilazapril
				
			ciprofloxacin
				
			citalopram
				
				
					Ataxia: postmarketing, infrequent, uncommon cladribine
				
			clobazam
				
			clomipramine
				
				
					Ataxia: infrequent, uncommon clonazepam
				
			clorazepate
				
			clozapine
				
			copolymer 1
				
			cyclobenzaprine
				
			cyclopentolate
				
			cysteamine
				
			delta 9-THC
				
			deprenyl
				
				
					Ataxia: postmarketing, rare, 3% desipramine
				
			diazepam
				
			dichlorphenamide
				
			docetaxel
				
			dolasetron
				
			donepezil
				
				
					Ataxia: infrequent, frequent dothiepin
				
			doxazosin
				
			doxepin
				
			doxorubicin
				
			duloxetine
				
			efavirenz
				
				
					Ataxia: postmarketing, uncommon eletriptan
				
			entacapone
				
			eprosartan
				
			eslicarbazepine
				
			eslicarbazepine acetate
				
			estazolam
				
			ethosuximide
				
			ethotoin
				
			felbamate
				
			flecainide
				
			fluconazole
				
			flumazenil
				
			flunitrazepam
				
			fluoxetine
				
				
					Ataxia: infrequent, uncommon flurazepam
				
			flurbiprofen
				
			fluvoxamine
				
				
					Ataxia: infrequent, uncommon foscarnet
				
			fosphenytoin
				
			frovatriptan
				
			gabapentin
				
			gadodiamide
				
			galantamine
				
				
					Ataxia: infrequent, frequent ganciclovir
				
			gatifloxacin
				
			guanidinium
				
			hexamethylmelamine
				
			homatropine
				
			hydrochlorothiazide
				
			hydroxybutyrate
				
			hydroxychloroquine
				
			imipramine
				
			indapamide
				
			iopamidol
				
			isocarboxazid
				
			lacosamide
				
			lamotrigine
				
			lenalidomide
				
			leuprorelin acetate
				
			levetiracetam
				
			levobunolol
				
			levodopa/carbidopa
				
			lithium
				
			lithium carbonate
				
			lomefloxacin
				
			lomustine
				
			lorazepam
				
			lormetazepam
				
			losartan
				
			maprotiline
				
			medroxyprogesterone acetate
				
			mefloquine
				
			memantine
				
			mephenytoin
				
			meprobamate
				
			methotrexate
				
			methsuximide
				
			methysergide
				
			metronidazole
				
			mexiletine
				
			midazolam
				
			miglustat
				
			minocycline
				
			mirtazapine
				
			mitotane
				
			modafinil
				
			morphine
				
			mycophenolic acid
				
			nabilone
				
				
					Ataxia: postmarketing, 0% - 19% nefazodone
				
			nelarabine
				
			nifedipine
				
			nisoldipine
				
			nitrazepam
				
			norfloxacin
				
			nortriptyline
				
			ofloxacin
				
			olanzapine
				
			oxaliplatin
				
			oxazepam
				
			oxcarbazepine
				
			paclitaxel
				
				
					Ataxia: very rare, postmarketing paroxetine
				
				
					Ataxia: rare, infrequent, uncommon pentobarbital
				
			pentostatin
				
			perampanel
				
			pergolide
				
			perhexiline
				
			perphenazine
				
			phenelzine
				
			phenobarbital
				
			phenylpropanolamine
				
			phenytoin
				
			polymyxin B
				
			posaconazole
				
			pramipexole
				
			pregabalin
				
			primidone
				
			procarbazine
				
			propafenone
				
				
					Ataxia: postmarketing, 0% - 2% propoxyphene
				
			protriptyline
				
			quetiapine
				
			quinidine
				
			rasagiline
				
			ribavirin
				
			rifampicin
				
			riluzole
				
			rimantadine
				
			risperidone
				
			ritonavir
				
			rivastigmine
				
			rizatriptan
				
			ropinirole
				
			rufinamide
				
			salbutamol
				
			saquinavir
				
			secobarbital
				
			sertraline
				
			sibutramine
				
			sildenafil
				
			sitaxsentan
				
			sparfloxacin
				
			spironolactone
				
			stiripentol
				
			sulfadiazine
				
			sulfamethoxazole
				
			sulfasalazine
				
			tapentadol
				
			temazepam
				
			temozolomide
				
				
					Ataxia: uncommon, 1.9% - 7.59% tetrabenazine
				
			thalidomide
				
			thiotepa
				
			tiagabine
				
			tinidazole
				
			topiramate
				
				
					Ataxia: postmarketing, 1% - 21.2% toremifene
				
			tramadol
				
				
					Ataxia: postmarketing, uncommon tranylcypromine
				
			trazodone
				
			triazolam
				
			trimethoprim
				
			trimethoprim-sulfamethoxazole
				
			trimipramine
				
			trovafloxacin
				
			valganciclovir
				
			valproate
				
			venlafaxine
				
			vigabatrin
				
			vincristine
				
			voriconazole
				
			zalcitabine
				
			zaleplon
				
			ziconotide
				
			ziprasidone
				
				
					Ataxia: uncommon, frequent zolmitriptan
				
			zolpidem
				
				
					Ataxia: postmarketing, rare, frequent, 1% zonisamide
				
			zopiclone
				
			zuclopenthixol
				
			 | Drugs with this indication |